JP2006528650A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006528650A5 JP2006528650A5 JP2006521498A JP2006521498A JP2006528650A5 JP 2006528650 A5 JP2006528650 A5 JP 2006528650A5 JP 2006521498 A JP2006521498 A JP 2006521498A JP 2006521498 A JP2006521498 A JP 2006521498A JP 2006528650 A5 JP2006528650 A5 JP 2006528650A5
- Authority
- JP
- Japan
- Prior art keywords
- immunogenic composition
- composition according
- amino acid
- peptide
- conjugate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0309188A FR2857875A1 (fr) | 2003-07-25 | 2003-07-25 | Vaccin therapeutique cible contre la p-glycoproteine 170 pour inhiber la resistance multidrogues dans le traitement des cancers |
| PCT/EP2004/008330 WO2005014036A1 (fr) | 2003-07-25 | 2004-07-25 | Vaccin therapeutique cible contre la p-glycoproteine 170 pour inhiber la resistance multidrogues dans le traitement des cancers |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013018233A Division JP2013121977A (ja) | 2003-07-25 | 2013-02-01 | 癌の治療における多剤耐性を抑制するための、ｐ−糖タンパク質１７０を標的とする治療ワクチン |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006528650A JP2006528650A (ja) | 2006-12-21 |
| JP2006528650A5 true JP2006528650A5 (https=) | 2007-08-30 |
Family
ID=33561147
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006521498A Pending JP2006528650A (ja) | 2003-07-25 | 2004-07-25 | 癌の治療における多剤耐性を抑制するための、ｐ−糖タンパク質１７０を標的とする治療ワクチン |
| JP2013018233A Withdrawn JP2013121977A (ja) | 2003-07-25 | 2013-02-01 | 癌の治療における多剤耐性を抑制するための、ｐ−糖タンパク質１７０を標的とする治療ワクチン |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013018233A Withdrawn JP2013121977A (ja) | 2003-07-25 | 2013-02-01 | 癌の治療における多剤耐性を抑制するための、ｐ−糖タンパク質１７０を標的とする治療ワクチン |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20060233758A1 (https=) |
| EP (2) | EP1651257B1 (https=) |
| JP (2) | JP2006528650A (https=) |
| KR (2) | KR20130008092A (https=) |
| CN (1) | CN1856323B (https=) |
| AU (1) | AU2004262472B2 (https=) |
| CA (1) | CA2533540C (https=) |
| FR (1) | FR2857875A1 (https=) |
| WO (1) | WO2005014036A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8663650B2 (en) * | 2003-02-21 | 2014-03-04 | Ac Immune Sa | Methods and compositions comprising supramolecular constructs |
| US20080026995A1 (en) * | 2003-07-25 | 2008-01-31 | Ac Immune Sa | Therapeutic vaccine targeted against p-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers |
| US7807171B2 (en) * | 2003-07-25 | 2010-10-05 | Ac Immune Sa | Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers |
| US8090392B2 (en) * | 2005-08-05 | 2012-01-03 | Interdigital Technology Corporation | Method and system for reporting a short message capability via an IP multimedia subsystem |
| PT2468300T (pt) | 2006-09-26 | 2018-01-30 | Infectious Disease Res Inst | Composição para vacina contendo adjuvante sintético |
| KR101130754B1 (ko) * | 2010-06-25 | 2012-03-28 | 제일약품주식회사 | 난용성 트리사이클릭 유도체 화합물의 용해도가 향상된 약학적 조성물 |
| EP3527220A1 (en) | 2010-08-12 | 2019-08-21 | AC Immune S.A. | Vaccine engineering |
| AR083561A1 (es) | 2010-10-26 | 2013-03-06 | Ac Immune Sa | Preparacion de una construccion antigenica |
| KR102136433B1 (ko) | 2012-05-16 | 2020-07-22 | 이뮨 디자인 코포레이션 | Hsv-2 백신 |
| EP2986303B1 (en) | 2013-04-18 | 2020-02-26 | Immune Design Corp. | Gla monotherapy for use in cancer treatment |
| CA3118692A1 (en) | 2018-11-06 | 2020-05-14 | Alsatech, Inc. | Cell-based gene therapy for neurodegenerative diseases |
| CN109887553B (zh) * | 2019-01-29 | 2021-01-26 | 杭州纽安津生物科技有限公司 | 针对肿瘤靶向药物耐药位点的多肽疫苗及其设计方法 |
| WO2021212026A2 (en) * | 2020-04-17 | 2021-10-21 | Intarcia Therapeutics, Inc. | Long acting glucagon receptor selective peptides and methods of use |
| CN113648429B (zh) * | 2021-07-06 | 2023-11-10 | 中山大学 | 靶向肿瘤周围细胞激活免疫的聚合物及其制备方法与应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1257893B (it) * | 1992-06-17 | 1996-02-16 | Ist Superiore Sanita | Anticorpi monoclonali che riconoscono un epitopo della p-glicoproteina umana. |
| AU5420494A (en) * | 1992-11-02 | 1994-05-24 | Yves Claude Nicolau | Method of reducing multidrug resistance in cells and tissues |
| JP3759759B2 (ja) * | 1994-03-04 | 2006-03-29 | 日本油脂株式会社 | リポソームおよび薬物運搬体 |
| JP4385152B2 (ja) * | 1997-09-17 | 2009-12-16 | 三菱化学株式会社 | ２価反応性水溶性高分子誘導体及びそれを含有する複合体 |
| JP2002047298A (ja) * | 2000-07-10 | 2002-02-12 | Academia Sinica | 新規抗がん剤伝達系 |
| US8663650B2 (en) * | 2003-02-21 | 2014-03-04 | Ac Immune Sa | Methods and compositions comprising supramolecular constructs |
| WO2004100997A2 (en) * | 2003-05-12 | 2004-11-25 | Affymax, Inc. | Spacer moiety for poly(ethylene glycol) -modified peptides |
-
2003
- 2003-07-25 FR FR0309188A patent/FR2857875A1/fr not_active Withdrawn
-
2004
- 2004-07-25 KR KR1020127033292A patent/KR20130008092A/ko not_active Ceased
- 2004-07-25 KR KR1020067001783A patent/KR20060125676A/ko not_active Ceased
- 2004-07-25 EP EP04763487.8A patent/EP1651257B1/fr not_active Expired - Lifetime
- 2004-07-25 CN CN2004800274241A patent/CN1856323B/zh not_active Expired - Fee Related
- 2004-07-25 JP JP2006521498A patent/JP2006528650A/ja active Pending
- 2004-07-25 EP EP10185331.5A patent/EP2316478B1/fr not_active Expired - Lifetime
- 2004-07-25 AU AU2004262472A patent/AU2004262472B2/en not_active Ceased
- 2004-07-25 WO PCT/EP2004/008330 patent/WO2005014036A1/fr not_active Ceased
- 2004-07-25 CA CA2533540A patent/CA2533540C/fr not_active Expired - Fee Related
-
2005
- 2005-11-16 US US11/274,885 patent/US20060233758A1/en not_active Abandoned
-
2013
- 2013-02-01 JP JP2013018233A patent/JP2013121977A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006528650A5 (https=) | ||
| Moyle et al. | Site-specific incorporation of three toll-like receptor 2 targeting adjuvants into semisynthetic, molecularly defined nanoparticles: application to group a streptococcal vaccines | |
| JP2013121977A5 (https=) | ||
| Pöltl-Frank et al. | Use of reconstituted influenza virus virosomes as an immunopotentiating delivery system for a peptide-based vaccine | |
| JP2009510133A5 (https=) | ||
| JP2013121977A (ja) | 癌の治療における多剤耐性を抑制するための、ｐ−糖タンパク質１７０を標的とする治療ワクチン | |
| US8409580B2 (en) | Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers | |
| CN111499753B (zh) | 双功能抗体及其用途 | |
| JP5519477B2 (ja) | Ｔ１免疫応答とｔ２免疫応答との間で調節するためのワクチン | |
| JP2014503475A5 (https=) | ||
| JP2014518841A (ja) | アジュバントを備えたｍｕｃ１ベースのグリコリポペプチドワクチン | |
| CN110790829B (zh) | pHLIP胞外段作为抗原制备的抗体在制备抗肿瘤药物中的应用 | |
| US12280109B2 (en) | Nano-particles that contain synthetic variants of GM3 ganglioside as adjuvants in vaccines | |
| Wallis et al. | A liposome-based cancer vaccine for a rapid and high-titre anti-ErbB-2 antibody response | |
| US7314956B2 (en) | Multifunctional carrier for the delivery of a pharmacological agent or genetic material into a cell | |
| JP2001510440A (ja) | ムチン接合体ペプチドワクチン | |
| JP2008545759A (ja) | コレステリルエステル転送タンパク質（ｃｅｔｐ）活性の調節 | |
| US20080175871A1 (en) | Eliciting improved immune responses | |
| WO2019120063A1 (zh) | 低pH插入肽及其组合物 | |
| CN1446094A (zh) | 获得可增强特异交叉反应性的抗原结构的方法 | |
| US20050255561A1 (en) | Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers | |
| JPWO2022060488A5 (https=) | ||
| Luna González | Peptides: from synthesis to biomedical application in two types of cancer | |
| González | Peptides: From Synthesis to Biomedical Application in Two Types of Cancer | |
| JP2004509846A (ja) | 肝炎ｃ型ウイルスコンジュゲート |